Compare TTEC & TMCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TTEC | TMCI |
|---|---|---|
| Founded | 1982 | 2014 |
| Country | United States | United States |
| Employees | 69400 | N/A |
| Industry | Retail: Computer Software & Peripheral Equipment | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 128.5M | 120.4M |
| IPO Year | 1996 | 2021 |
| Metric | TTEC | TMCI |
|---|---|---|
| Price | $2.36 | $4.14 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 2 | 6 |
| Target Price | N/A | ★ $4.77 |
| AVG Volume (30 Days) | 455.3K | ★ 636.3K |
| Earning Date | 05-07-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 40.80 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $1,509,171,000.00 | $212,690,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $0.10 | $8.18 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 2.15 | 1.59 |
| 52 Week Low | $1.98 | $1.17 |
| 52 Week High | $5.59 | $7.78 |
| Indicator | TTEC | TMCI |
|---|---|---|
| Relative Strength Index (RSI) | 44.42 | 72.19 |
| Support Level | $2.12 | $2.46 |
| Resistance Level | $2.74 | $7.08 |
| Average True Range (ATR) | 0.17 | 0.31 |
| MACD | -0.02 | 0.05 |
| Stochastic Oscillator | 38.89 | 81.08 |
TTEC Holdings Inc provides customer engagement management tools and services. The company operates through two operating segment, TTEC Digital and TTEC Engage. TTEC Digital is engaged in building and implementing cloud-based and on-premises customer experience tools that enable clients to develop customer engagement strategies. TTEC Engage focuses on delivering sales and marketing solutions to help clients boost their revenue as well as on managing customer's front-to-back office processes to optimize the customer experience. TTEC Engage contributes the vast majority of the company's revenue, and its revenues are derived from the United States and Canada, followed by Philippines, Asia-Pacific and India.
Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The Company operates and manages its business as one segment, which is the business of designing, manufacturing, and marketing medical devices for physicians, surgeons, ambulatory surgery centers and hospitals.